Aurobindo Pharma informs about disclosure

10 Jul 2020 Evaluate

Aurobindo Pharma has informed that exchange has received disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 10, 2020 for RPR Sons Advisors, and P. Suneela Rani (jointly holding).

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1087.10 -27.80 (-2.49%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.